Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review

  • J. Han van Krieken1Email author,
  • George Kafatos2,
  • James Bennett2,
  • Laurent Mineur3,
  • Jiří Tomášek4,
  • Etienne Rouleau5,
  • Pavel Fabian4,
  • Giovanna De Maglio6,
  • Pilar García-Alfonso7,
  • Giuseppe Aprile6,
  • Parijan Parkar2,
  • Gerald Downey8,
  • Gaston Demonty9 and
  • Jörg Trojan10
BMC Cancer201717:798

https://doi.org/10.1186/s12885-017-3740-4

Received: 14 April 2016

Accepted: 31 October 2017

Published: 28 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Apr 2016 Submitted Original manuscript
11 Nov 2016 Reviewed Reviewer Report - Paul Ruff
17 Nov 2016 Reviewed Reviewer Report - Amanda Townsend
24 Jan 2017 Author responded Author comments - Han van Krieken
Resubmission - Version 2
24 Jan 2017 Submitted Manuscript version 2
17 Feb 2017 Author responded Author comments - Han van Krieken
Resubmission - Version 3
17 Feb 2017 Submitted Manuscript version 3
25 May 2017 Reviewed Reviewer Report - Timothy Price
27 Oct 2017 Author responded Author comments - Han van Krieken
Resubmission - Version 4
27 Oct 2017 Submitted Manuscript version 4
Publishing
31 Oct 2017 Editorially accepted
28 Nov 2017 Article published 10.1186/s12885-017-3740-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Radboud University Medical Center
(2)
Amgen Ltd
(3)
Institute Sainte Catherine
(4)
Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University
(5)
Curie Institute
(6)
University and General Hospital
(7)
Gregorio Marañón Hospital
(8)
Amgen Ltd
(9)
Amgen GmbH
(10)
University Hospital

Advertisement